van OppenraaiRBergenNDuvekotJ. Placental vascularization in early onset small for gestational age and preeclampsia. Reprod Sci. 2011;18(6):586–593.
3.
HutcheonJALisonkovaSJosephKS. Epidemiology of preeclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):391–403.
4.
KakiganoATomimatsuTMimuraK. Drug repositioning for preeclampsia therapeutics by in vitro screening: phosphodiesterase-5 inhibitor vardenafil restores endothelial dysfunction via induction of placental growth factor. Reprod Sci. 2015;22(10):1272–1280.
5.
BergmanLÅkerudH. Plasma levels of the cerebral biomarker, neuron-specific enolase, are elevated during pregnancy in women developing preeclampsia. Reprod Sci. 2016;23(3):395–400.
6.
FoundsSRenDRobertsJJeyabalanAPowersR. Follistatin-like 3 across gestation in preeclampsia and uncomplicated pregnancies among lean and obese women. Reprod Sci. 2015;22(4):402–409.
7.
KrauseEGRabitzschGNollFMairJPuschendorfB. Glycogen phosphorylase isoenzyme BB in diagnosis of myocardial ischaemic injury and infarction. Mol Cell Biochem. 1996;160-161:289–295.
8.
RobsonSCHunterSBoysRJDunlopW. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989;256(4 pt 2):h1060–h1065.
9.
KennyLCBlackMAPostonL. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy Endpoints (SCOPE) International Cohort Study. Hypertension. 2014;64(3):644–652.
10.
McCarthyFDoyleAKhashanAKennyL. Altered maternal plasma glycogen phosphorylase isoenzyme BB as a biomarker for preeclampsia and small for gestational age. Reprod Sci. 2016;23(6):738–747.
